deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT02491060

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Sponsor: Valeant Pharmaceuticals

Conditions Acne Vulgaris
Updated 7 times since 2017 Last updated: Sep 11, 2015 Started: Sep 30, 2015 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Acne Vulgaris, this trial is ongoing. The trial is conducted by Valeant Pharmaceuticals and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshotNot Yet Recruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Oct 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    Status: Not Yet RecruitingUnknown Status

Show 2 earlier versions
  1. Feb 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE3

  2. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Valeant Pharmaceuticals
Data source: Valeant Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.